Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity

Charlotte Boussard, Laure Delage, Tania Gajardo, Alexandre Kauskot, Maxime Batignes, Nicolas Goudin, Marie-Claude Stolzenberg, Camille Brunaud, Patricia Panikulam, Quentin Riller, Maryse Moya-Nilges, Jean Solarz, Christelle Repérant, Béatrice Durel, Jean-Claude Bordet, Olivier Pellé, Corinne Lebreton, Aude Magérus, Vithura Pirabakaran, Pablo Vargas, Sébastien Dupichaud, Marie Jeanpierre, Angélique Vinit, Mohammed Zarhrate, Cécile Masson, Nathalie Aladjidi, Peter D. Arkwright, Brigitte Bader-Meunier, Sandrine Baron Joly, Joy Benadiba, Elise Bernard, Dominique Berrebi, Christine Bodemer, Martin Castelle, Fabienne Charbit-Henrion, Marwa Chbihi, Agathe Debray, Philippe Drabent, Sylvie Fraitag, Miguel Hié, Judith Landman-Parker, Ludovic Lhermitte, Despina Moshous, Pierre Rohrlich, Frank Ruemmele, Anne Welfringer-Morin, Maud Tusseau, Alexandre Belot, Nadine Cerf-Bensussan, Marie Roelens, Capucine Picard, Bénédicte Neven, Alain Fischer, Isabelle Callebaut, Mickaël Ménager, Fernando E. Sepulveda, Frédéric Adam, Frédéric Rieux-Laucat

Blood (2023) 141 (22): 2713–2726.

https://doi.org/10.1182/blood.2022018486

Published: 2023

Includes: Supplemental data

Journal Articles

The Eatl-001 Trial: Results of a Phase 2 Study of Brentuximab Vedotin and CHP Followed By Consolidation with High-Dose Therapy - Autologous Stem-Cell Transplantation (HDT-ASCT) in the Frontline Treatment of Patients with Enteropathy-Associated T-Cell Lymphoma

David Sibon, Sherine Khater, Julie Bruneau, Chantal Brouzes, Ludovic Lhermitte, Thierry Jo Molina, Guillaume Cartron, Veronique Morel, Georgia Malamut, Adrien Chauchet, Franck Morschhauser, Baptiste Perard, Jean-Michel Boulet, Anne-Cécile Gauchy, Nadine Cerf-Bensussan, Elizabeth A. Macintyre, Vahid Asnafi, Christophe Cellier, Olivier Hermine

Blood (2021) 138 (Supplement 1): 136.

https://doi.org/10.1182/blood-2021-153709

Published: 2021

Journal Articles

NKp46 Is a Useful Diagnostic Biomarker in Gastrointestinal T-Cell Lymphoproliferative Diseases and Constitutes a Therapeutic Target. a Celac Network Study

Morgane Cheminant, MD, Julie Bruneau, MD PhD, Georgia Malamut, MD PhD, David Sibon, Nicolas Guegan, Sascha Cording, PhD, Amélie Trinquand, MD PhD, Nicole Brousse, MD PhD, Sherine Khater, MD, Elizabeth A. Macintyre, PhD FRCP, FRCPath, Vahid Asnafi, MD PhD, Laurent Pouyet, PhD, Florence Lhospice, PharmD, Thierry Jo Molina, MDPhD, Bertrand Meresse, PhD, Christophe Cellier, MD PhD, Nadine Cerf-Bensussan, MD PhD, Olivier Hermine, MD PhD

Blood (2017) 130 (Supplement 1): 2820.

https://doi.org/10.1182/blood.V130.Suppl_1.2820.2820

Published: 2017

Journal Articles

Enteropathy-Associated T-Cell Lymphoma Type I, But Not Refractory Celiac Disease, Strongly Expresses CD30 and Might Benefit From Brentuximab Vedotin

David Sibon, MD, PhD, Georgia Malamut, MD, PhD, Virginie Verkarre, MD, PhD, Coralie Derrieux, MD, Isabelle Radford, MD, Bertrand Meresse, PhD, Elizabeth Macintyre, MD, PhD, Christophe Cellier, MD, PhD, Nadine Cerf-Bensussan, MD, PhD, Nicole Brousse, M.D., Olivier Hermine

Blood (2013) 122 (21): 4252.

https://doi.org/10.1182/blood.V122.21.4252.4252

Published: 2013

Journal Articles

The Type of Enteropathy Is a Prognostic Factor in Enteropathy-Associated T-Cell Lymphoma.

Marie-Olivia Chandesris, Georgia Malamut, Virginie Verkarre, Bertrand Meresse, Gabriel Rahmi, Elizabeth Macintyre, Nicole Brousse, Nadine Cerf-Bensussan, Christophe Cellier, Olivier Hermine

Blood (2009) 114 (22): 2937.

https://doi.org/10.1182/blood.V114.22.2937.2937

Published: 2009

Journal Articles

Is Complicated Celiac Disease or Refractory Sprue an Intestinal Intra-Epithelial Cryptic T-Cell Lymphoma?

Nicole Brousse, Virginie Verkarre, Natacha Patey-Mariaud de Serre, Christophe Cellier, Nadine Cerf-Bensussan, Eric Delabesse, Elisabeth Macintyre

Blood (1999) 93 (9): 3154–3155.

https://doi.org/10.1182/blood.V93.9.3154a

Published: 1999

NARROW

DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity

The Eatl-001 Trial: Results of a Phase 2 Study of Brentuximab Vedotin and CHP Followed By Consolidation with High-Dose Therapy - Autologous Stem-Cell Transplantation (HDT-ASCT) in the Frontline Treatment of Patients with Enteropathy-Associated T-Cell Lymphoma

NKp46 Is a Useful Diagnostic Biomarker in Gastrointestinal T-Cell Lymphoproliferative Diseases and Constitutes a Therapeutic Target. a Celac Network Study

Enteropathy-Associated T-Cell Lymphoma Type I, But Not Refractory Celiac Disease, Strongly Expresses CD30 and Might Benefit From Brentuximab Vedotin

The Type of Enteropathy Is a Prognostic Factor in Enteropathy-Associated T-Cell Lymphoma.

Is Complicated Celiac Disease or Refractory Sprue an Intestinal Intra-Epithelial Cryptic T-Cell Lymphoma?

Email alerts

ASH Publications

American Society of Hematology

DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity

The Eatl-001 Trial: Results of a Phase 2 Study of Brentuximab Vedotin and CHP Followed By Consolidation with High-Dose Therapy - Autologous Stem-Cell Transplantation (HDT-ASCT) in the Frontline Treatment of Patients with Enteropathy-Associated T-Cell Lymphoma

NKp46 Is a Useful Diagnostic Biomarker in Gastrointestinal T-Cell Lymphoproliferative Diseases and Constitutes a Therapeutic Target. a Celac Network Study

Enteropathy-Associated T-Cell Lymphoma Type I, But Not Refractory Celiac Disease, Strongly Expresses CD30 and Might Benefit From Brentuximab Vedotin

The Type of Enteropathy Is a Prognostic Factor in Enteropathy-Associated T-Cell Lymphoma.

Is Complicated Celiac Disease or Refractory Sprue an Intestinal Intra-Epithelial Cryptic T-Cell Lymphoma?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only